Maya Balakrishnan

Maya Balakrishnan, M.D. is an Associate Professor in the Department of Medicine at Baylor College of Medicine, Houston, Texas. She practices at Ben Taub Hospital and holds dual certifications in Internal Medicine and Gastroenterology/Hepatology from the American Board of Internal Medicine.

• Education: BA from Rice University, MD and MPH from Harvard University
• Training: Residency and Fellowship at Yale University

Her research focuses on Fatty Liver Disease, Metabolic Syndrome, and Chronic Liver Disease Epidemiology. Recent work examines global liver disease burden, pharmacologic interventions in NASH, and metabolic risk factors for hepatocellular carcinoma.

Key publications include:

• 2025: Semaglutide for Metabolic Dysfunction-Associated Steatohepatitis
• 2024: Global burden mitigation strategies
• 2023: Fibrosis marker tracking in NAFLD

Scientific recognition includes the Samuel Kushlan Award for Excellence in Research (Yale University) and Chief Medical Resident at Yale. She contributes to clinical guidelines like Treatment of Dyslipidemia in Liver Diseases (2018).